|
|
||||||||||
1-Adrenergic Receptor AntagonistsClinical Pharmacy Specialist, Veterans Affairs Medical Center, Iowa City, IA; Assistant Professor (Clinical), College of Pharmacy, University of Iowa, Iowa City
Clinical Pharmacy Specialist-Surgery/Transplant, Veterans Affairs Medical Center, Iowa City; Assistant Professor (Clinical), College of Pharmacy, University of Iowa
Resident Physician, Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa
PGY-1-Ambulatory Care Resident, Veterans Affairs Medical Center, Iowa City; Adjunct Instructor, College of Pharmacy, University of Iowa
PGY-1-Ambulatory Care Resident, Veterans Affairs Medical Center, Iowa City; Adjunct Instructor, College of Pharmacy, University of Iowa
PGY-1-Ambulatory Care Resident, Veterans Affairs Medical Center, Iowa City; Adjunct Instructor, College of Pharmacy, University of Iowa
Reprints: Dr. Cantrell, Veterans Affairs Medical Center, 601 Highway 6 W., Iowa City, IA 52246, fax 319/887-4951, matthew-cantrell{at}uiowa.edu
OBJECTIVE: To describe intraoperative floppy iris syndrome (IFIS) in
association with
1-adrenergic receptor
(
1AR) antagonists by conducting a thorough literature
review.
DATA SOURCES: Literature retrieval was accomplished by searching
MEDLINE (2000-December 2007) using the terms intraoperative floppy iris
syndrome (IFIS), adrenergic
-antagonist(s), tamsulosin, doxazosin,
terazosin, and/or alfuzosin. In addition, reference lists from identified
publications were reviewed to identify additional reports and studies of
interest.
STUDY SELECTION AND DATA EXTRACTION: All articles in English identified from data sources were reviewed for relevance and uniqueness prior to inclusion.
DATA SYNTHESIS: IFIS was first described in 2005 as a clinical triad
observed during cataract surgery that includes fluttering and billowing of the
iris stroma, propensity for iris prolapse, and constriction of the pupil. IFIS
increases the risk of complications during cataract surgery. Numerous reports
have linked IFIS to use of
1AR antagonists, most
notably tamsulosin, which is prescribed for benign prostatic hyperplasia.
Tamsulosin blocks prostatic
1AARs but may also
selectively block
1AARs in the iris dilator muscle,
preventing mydriasis during cataract surgery. Other
1AR antagonists, including terazosin, doxazosin, and
alfuzosin, have also been linked to IFIS; however, their relationship to the
syndrome is not as definitive. When ophthalmologists are aware of a patient's
previous
1AR antagonist exposure, specific steps can
be taken to reduce the risk of surgical complications. Corrective measures
used during surgery have included iris expansion hooks, intracameral
phenylephrine, and preoperative atropine.
CONCLUSIONS: IFIS is a clinical syndrome observed during cataract
surgery reported in patients taking systemic
1AR
antagonists. It has been most strongly linked to use of tamsulosin. Medication
washout periods of up to 2 weeks and specific surgical procedures have been
attempted to reduce risk of complications from
1AR
antagonists in the setting of cataract surgery. Patients should be educated
regarding potential risks of this drug class so that they can discuss them
with their healthcare providers, specifically ophthalmologists, prior to
cataract surgery.
Key Words:
-adrenergic antagonists, alfuzosin, doxazosin, intraoperative floppy iris syndrome (IFIS), tamsulosin, terazosin
Published Online, March 25, 2008. www.theannals.com, DOI 10.1345/aph.1K679